Moreover, β-arrestin1 is also necessary for endothelin-1-induced NF-κB activation in ovarian cancer cells since Cianfrocca et al. (2014) discovered a previously unrecognized pathway dependent on β-arrestin1 to sustain NF-κB signaling in ovarian cancer. This evidence concerns the gene NFKB1 and ovarian cancer.